Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01BUT
|
||||
Former ID |
DIB007389
|
||||
Drug Name |
LXT-101
|
||||
Synonyms |
DepoLXT-101; GnRH antagonist (sustained release, prostate cancer), Beijing Institute of Pharmacology and Toxicology
|
||||
Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Investigative | [528301] | ||
Company |
Beijing Institute of Pharmacology and Toxicology
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Gonadotropin-releasing hormone receptor | Target Info | Antagonist | [528301] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.